- $10.26bn
- $10.66bn
- $3.69bn
Brief: Donaldson Company, Polypeptide Partner To Improve Sustainability In Peptide Manufacturing With Solvent Recovery Technology
Brief: Donaldson Enters Into Agreement To Acquire Minority Stake In Medica, S.P.A.
Donaldson Company Inc reports results for the quarter ended in January - Earnings Summary
Brief: Donaldson Company Q2 Sales USD 876.7 Million Vs. IBES Estimate USD 873.6 Million
Donaldson Company Inc expected to post earnings of 74 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP-Eli Lilly, Five Below, Synopsys
Donaldson Company Inc reports results for the quarter ended in October - Earnings Summary
Brief: Donaldson Company Q1 Sales USD 846.3 Million Vs. IBES Estimate USD 855.1 Million
Donaldson Company Inc expected to post earnings of 72 cents a share - Earnings Preview
Brief: Donaldson Company Announces Quarterly Cash Dividend And New Share Repurchase Program
Donaldson Company Inc reports results for the quarter ended in July - Earnings Summary
Brief: Donaldson Reports Fourth Quarter And Record Fiscal Year 2023 Earnings
Brief: Donaldson Company Q4 Sales USD 879.5 Million Vs. IBES Estimate USD 895.9 Million
Donaldson Company Inc expected to post earnings of 78 cents a share - Earnings Preview
Brief: Gamma Biosciences Says Univercells Technologies Acquired By Donaldson Company
Brief: Donaldson Acquires Univercells Technologies, Broadens Life Sciences Reach
Atmus Filtration rises; JPM starts at "overweight" after IPO quiet period ends
Donaldson Company Inc reports results for the quarter ended in April - Earnings Summary
Brief: Donaldson Company Sees FY Adjusted EPS USD 3-3.06